Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Buildings (2016 - 2024)

National Healthcare's Buildings history spans 14 years, with the latest figure at $835.9 million for Q4 2024.

  • For Q4 2024, Buildings rose 19.4% year-over-year to $835.9 million; the TTM value through Dec 2024 reached $835.9 million, up 19.4%, while the annual FY2024 figure was $835.9 million, 19.4% up from the prior year.
  • Buildings reached $835.9 million in Q4 2024 per NHC's latest filing, up from $700.0 million in the prior quarter.
  • In the past five years, Buildings ranged from a high of $835.9 million in Q4 2024 to a low of $641.4 million in Q4 2020.
  • Average Buildings over 5 years is $704.1 million, with a median of $688.4 million recorded in 2022.
  • Peak YoY movement for Buildings: decreased 0.45% in 2020, then rose 19.4% in 2024.
  • A 5-year view of Buildings shows it stood at $641.4 million in 2020, then increased by 2.07% to $654.7 million in 2021, then grew by 5.16% to $688.4 million in 2022, then increased by 1.69% to $700.0 million in 2023, then rose by 19.4% to $835.9 million in 2024.
  • Per Business Quant, the three most recent readings for NHC's Buildings are $835.9 million (Q4 2024), $700.0 million (Q4 2023), and $688.4 million (Q4 2022).